CLINICAL AND SUBCLINICAL CHARACTERISTICS IN PATIENTS WITH CHRONIC PULMONARY ASPERGILLOSIS

Văn Long Trần1, Bá Thắng Tạ 1, Thị Bích Ngọc Nguyễn2, Ngọc Bằng Đào 1, Lam Nguyễn1,
1 103 Military Hospital
2 National lung hospital

Main Article Content

Abstract

Objectives: To describe clinical and subclinical characteristics in patients with chronic pulmonary aspergillosis (CPA). Subjects and methods: A retrospective, prospective, cross-sectional study on 50 patients with CPA who were diagnosed and treated at the National Lung Hospital from January 2022 to November 2022. Results: The mean age is 57 ± 11years old, with the proportion of men being 78%. History of pulmonary tuberculosis accounts for the highest rate (76%), following by diabetes (20%). The time of disease detection is late with an average time of 8.22 ± 10.4 months. Common clinical symptoms are cough, sputum production (72%) and hemoptysis (56%). Lesions on chest CT are mainly in the upper lobe (95%), with cavities (86%) and aspergilloma (76%). Fungal culture with positive results accounts for 26.7% - 36.4%, in which Aspergillus fumigatus accounts for 95%; Aspergillus Galactomannan test with positive results accounts for 80% - 97.1%. Conclusion: The disease is common in men, middle-aged, with a history of pulmonary tuberculosis and detected late. Cough, sputum production and hemoptysis are the main clinical manifestations. Radiographic lesions are predominantly in the upper lobes with predominant cavities and aspergilloma. Fungal cultures with positive results account for a low percentage and most of them are Aspergillus fumigatus. Aspergillus Galactomannan tests with positive results account for a high percentage.

Article Details

References

1. David W.D, Jacques C., Catherine B.A., (2016). Chronic pulmonary Aspergillois: rationale and clinical guidelines for diagnosis and management, ESR journals.
2. Nguyễn Thị Bích Ngọc, Lê Ngọc Huy, Nguyễn Viết Nhung, et al. (2021). Chronic Pulmonary Aspergillois Situation among Post Tuberculosis Patients in Vietnam: An Observational Study, Journal of Fungi, 7(7), 532.
3. Nguyễn Hoàng Bình, Vũ Hữu Vĩnh (2020). Phẫu thuật nội soi điều trị bệnh u nấm phổi Aspergilloma, Tạp chí phẫu thuật tim mạch và lồng ngực Việt Nam, 2020. 22, 43-47.
4. J. Beardsley, D. W. Denning, N. V. Chau (2015). Estimating the burden of fungal disease in Vietnam, Mycoses - Wiley Online Library.
5. Jhun B.W., Jeon K., Eom J.S., et al. (2013). Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis. Medical Mycology, 51(8), 811–817.
6. David L., Khaled A.S., Pippa J. N., et al. (2017). Predictors of mortality in chronic pulmonary aspergillosis, ERJ
7. Despois O., Chen S.C.-A., Gilroy N., et al. (2022). Chronic Pulmonary Aspergillosis: Burden, Clinical Characteristics and Treatment Outcomes at a Large Australian Tertiary Hospital. J. Fungi (Basel), 2022. Jan 25; 8(2), 110.
8. Agarwal R., Vishwanath G., Aggarwal A.N., et al. (2013). Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature. Mycoses, 56(5), 559–570.
9. Ohba H., Miwa S., Shirai M., et al. (2012). Clinical characteristics and prognosis of chronic pulmonary aspergillosis. Respiratory Medicine, 106(5), 724–729.
10. Hou X., Zhang H., Kou L., et al. (2017). Clinical features and diagnosis of chronic pulmonary aspergillosis in Chinese patients. Medicine (Baltimore), 2017 Oct; 96(42): e8315.